1 EYLEA (AFLIBERCEPT) | 10 of 410 | 5100 prescriptions Less than 1% of all prescriptions | | 890 patients 25% of all patients | < 11 | |
2 CIPROFLOXACIN HCL | 80 of 2020 | 3460 prescriptions Less than 1% of all prescriptions | | 1900 patients 52% of all patients | < 11 | A |
3 MOXIFLOXACIN (MOXIFLOXACIN HCL) | 480 of 3400 | 1770 prescriptions Less than 1% of all prescriptions | | 1090 patients 30% of all patients | < 11 | |
4 GENTAMICIN SULFATE | 70 of 550 | 1410 prescriptions Less than 1% of all prescriptions | | 1020 patients 28% of all patients | < 11 | A |
5 LUCENTIS (RANIBIZUMAB) | 10 of 110 | 740 prescriptions Less than 1% of all prescriptions | 740 | 140 patients 4% of all patients | 140 patients 4% of all patients | |
6 ILEVRO (NEPAFENAC) | 1010 of 2960 | 530 prescriptions Less than 1% of all prescriptions | | 180 patients 5% of all patients | < 11 | |
7 KETOROLAC TROMETHAMINE | 2100 of 6220 | 240 prescriptions Less than 1% of all prescriptions | | 120 patients 3% of all patients | < 11 | |
8 TOBRAMYCIN | 460 of 1300 | 350 prescriptions Less than 1% of all prescriptions | 350 | 260 patients 7% of all patients | 260 patients 7% of all patients | |
9 NEVANAC (NEPAFENAC) | 50 of 130 | 170 prescriptions Less than 1% of all prescriptions | 170 | < 11 | < 11 | |
10 PROLENSA (BROMFENAC SODIUM) | 1160 of 2770 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |